查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
心臟生物標誌物全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測
市場調查報告書
商品編碼
1264210

心臟生物標誌物全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測

Global Cardiac Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 167 Pages | 商品交期: 最快1-2個工作天內

價格

全球對心臟生物標誌物的需求預計將從 2022 年的 182 億美元增長到 2030 年的約 675.8 億美元，2023-2030 年調查期間的複合年增長率預計將達到 17.82%。

心臟生物標誌物是因心臟損傷或壓力而釋放到血液中的蛋白質分子。 這些生物標誌物可用於檢測心血管疾病 (ACS)，例如心肌缺血、心肌梗塞、充血性心力衰竭和急性冠脈綜合徵。 心臟生物標誌物測試使醫生能夠評估患者出現這種情況的可能性。 肌鈣蛋白、肌酸激□肌肉/腦 (CK-MB)、B 型鈉尿□ (BNP)、高敏 C 反應蛋白 (hs-CRP)、肌鈣蛋白 I 和 T、肌紅蛋白、缺血修飾白蛋白 (IMA)、其他心臟生物標誌物通常被用作心血管疾病 (CVD) 的綜合診斷方法。

市場動態：

隨著老年人口的增長以及因生活方式改變而患心髒病和胸部不適的患者數量的增加，預計該市場將得到提振。 心血管和生活方式疾病患病率的增加、對特定疾病治療的需求增加以及使用心臟生物標誌物的研究是推動市場增長的關鍵因素。 此外，心臟生物標誌物的技術進步和政府為提高人們對心血管疾病的認識而採取的積極舉措是推動心臟生物標誌物市場發展的主要因素。 此外，公共和私人機構增加對心臟生物標誌物研究的資助也有望在未來幾年推動市場增長。 然而，公眾意識低下預計會阻礙行業擴張。

這份研究報告描述了波特的五力模型、市場吸引力分析和價值鏈分析。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外，這些工具還對全球心臟生物標誌物市場的每個細分市場進行了全面評估。 心臟生物標誌物行業的發展和趨勢為這項研究提供了一種整體方法。

市場細分：

本部分按國家和地區提供詳細的細分數據，以幫助您確定目標受眾以及您的產品和服務的未來商機。

按類型

  • 心肌肌酸激□ (Ck-Mb)
  • 肌鈣蛋白（T 和 i）
  • 肌紅蛋白
  • 腦利鈉□ (Bnps) 或 Nt-Probnp
  • 缺血修飾白蛋白 (Ima)
  • 其他

按申請

  • 心肌梗塞
  • 充血性心力衰竭
  • 急性冠狀動脈綜合徵
  • 動脈粥樣硬化
  • 其他

按測試地點

  • 護理點測試
  • 實驗室測試

按地區分析：

本部分提供了北美、歐洲、亞太地區、拉丁美洲、中東和非洲心臟生物標誌物市場當前和未來需求的區域展望。 此外，它還側重於所有主要地區每個單獨應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 心臟生物標誌物市場的主要參與者是羅氏診斷、雅培實驗室、西門子醫療、Alere Inc.、Becton、Dickinson and Company、Bio-Rad Laboratories、BioMerieux、Randox laboratories、Beckman Coulter 和 Thermo Fisher Scientific。 本節全面介紹了競爭格局，包括各種戰略發展，例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。

如果您有任何定制要求，請寫信給我們。 我們的研究團隊可以根據您的需要提供定制報告。

內容

第一章前言

  • 報告內容
    • 目的
    • 目標受眾
    • USP（獨特的銷售建議）及其提供的內容
  • 調查範圍
  • 調查方法
    • 市場調研流程
    • 市場研究方法

第 2 章執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章心臟生物標誌物 - 行業分析

  • 簡介 - 市場動態
  • 市場驅動因素
  • 市場製約因素
  • 機會
  • 行業趨勢
  • 波特的五力分析
  • 市場吸引力分析
    • 按類型
    • 通過使用
    • 按測試位置
    • 按地區

第四章價值鏈分析

  • 價值鏈分析
  • 原材料分析
    • 原材料清單
    • 原材料製造商列表
    • 主要原材料價格走勢
  • 潛在買家名單
  • 營銷渠道
    • 直接營銷
    • 間接營銷
    • 市場發展趨勢

第 5 章 COVID-19 爆發的影響分析

第 6 章心臟生物標誌物的全球市場分析：按類型

  • 按類型概述
  • 過去和未來的數據
  • 按類型分析
  • 心肌肌酸激□ (CK-MB) 市場：按地區
  • 肌鈣蛋白（T 和 I）市場：按地區
  • 肌紅蛋白市場：區域細分
  • 腦利鈉□ (BNP) 或 NT-proBNP 市場：按地區
  • 缺血修飾白蛋白 (IMA) 市場：按地區
  • 其他市場：按地區

第 7 章心臟生物標誌物的全球市場分析：按應用

  • 總結：按應用
  • 過去和未來的數據
  • 分析：按應用
  • 心肌梗塞市場：區域細分
  • 充血性心力衰竭市場：按地區
  • 急性冠狀動脈綜合徵市場：按地區
  • 動脈粥樣硬化市場：按地區
  • 其他市場：按地區

第 8 章心臟生物標誌物的全球市場分析：按測試位置

  • 按測試位置列出大綱
  • 過去和未來的數據
  • 按測試地點分析
  • 即時檢驗市場：按地區
  • 實驗室檢測市場：按地區

第 9 章心臟生物標誌物的全球市場分析：按地區

  • 區域展望
  • 介紹
  • 北美
    • 摘要、實際數據、預測數據
    • 按北美細分
    • 北美：按國家/地區列出
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 摘要、實際數據、預測數據
    • 歐洲（按細分市場）
    • 歐洲：按國家/地區分類
    • 英國
    • 法國
    • 德國
    • 意大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 摘要、實際數據、預測數據
    • 按亞太地區細分
    • 亞太地區：國家/地區信息
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 拉丁美洲
    • 摘要、實際數據、預測數據
    • 拉丁美洲細分市場
    • 拉丁美洲：按國家/地區列出
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲地區
  • 中東和非洲
    • 摘要、實際數據、預測數據
    • 中東和非洲分部信息
    • 中東和非洲：按國家/地區列出
    • 沙特阿拉伯
    • 阿聯酋
    • 以色列
    • 南非
    • 其他中東和非洲地區

第10章心臟生物標誌物公司的競爭格局

  • 心臟生物標誌物市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他擴展

第11章公司簡介

  • 公司股票分析
  • 市場集中度
  • 羅氏診斷
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 雅培實驗室
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 西門子醫療
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • Alere 公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 貝頓
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 狄金森公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • Bio-Rad 實驗室
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 生物梅裡埃
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 朗道實驗室
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 貝克曼庫爾特
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 賽默飛世爾科技
    • 公司簡介
    • 產品介紹
    • 近期趨勢

注意：在公司簡介、財務細節、近期發展等方面，基於可用信息，私人控股公司可能不包括在內。

Product Code: VMR11217049

The global demand for Cardiac Biomarkers Market is presumed to reach the market size of nearly USD 67.58 BN by 2030 from USD 18.2 BN in 2022 with a CAGR of 17.82% under the study period 2023 - 2030.

Cardiac biomarkers are protein molecules released into the bloodstream due to cardiac injury or stress. These biomarkers could be used to detect cardiac ischemia, myocardial infarction, congestive heart failure, and acute coronary syndrome, among other cardiovascular illnesses (ACS). Cardiac biomarker testing enables doctors to assess a patient's likelihood of developing such conditions. Troponin, creatine kinase-muscle/brain (CK-MB), B-type natriuretic peptide (BNP), high-sensitivity C-reactive protein (hs-CRP), troponin I and T, myoglobin, ischemia modified albumin (IMA), and other cardiac biomarkers are commonly employed as an integrated diagnostic method for cardiovascular diseases (CVDs).

Market Dynamics:

The market will likely be fueled by an increase in the senior population and patients suffering from heart attacks and chest discomfort due to changing lifestyles. The increasing prevalence of cardiovascular diseases and lifestyle diseases, increase in demand for disease-specific treatment, and research in which cardiac biomarkers are used are significant elements boosting the market growth. In addition, technological advancements in cardiac biomarkers and favourable government initiatives to raise awareness about cardiovascular diseases are the key factors driving the cardiac biomarkers market. Moreover, increased funding for cardiac biomarker research from both public and private institutions is likely to support market growth in the coming years. However, a lack of public awareness is projected to stifle industry expansion

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cardiac biomarkers. The growth and trends of cardiac biomarkers industry provide a holistic approach to this study.

Market Segmentation:

This section of the cardiac biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Myocardial Muscle Creatine Kinase (Ck-Mb)
  • Troponins (T And I)
  • Myoglobin
  • Brain Natriuretic Peptide (Bnps) Or Nt-Probnp
  • Ischemia Modified Albumin (Ima)
  • Others

By Application

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

By Location of Testing

  • Point Of Care Testing
  • Laboratory Testing

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cardiac biomarkers market include Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux, Randox laboratories, Beckman Coulter and Thermo Fisher Scientific. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CARDIAC BIOMARKERS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Type
    • 3.7.2 By Application
    • 3.7.3 By Location of Testing
    • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Myocardial muscle Creatine Kinase (CK-MB) Market by Regions
  • 6.5 Troponins (T and I) Market by Regions
  • 6.6 Myoglobin Market by Regions
  • 6.7 Brain Natriuretic Peptide (BNPs) or NT-proBNP Market by Regions
  • 6.8 Ischemia Modified Albumin (IMA) Market by Regions
  • 6.9 Others Market by Regions

7 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Myocardial Infarction Market by Regions
  • 7.5 Congestive Heart Failure Market by Regions
  • 7.6 Acute Coronary Syndrome Market by Regions
  • 7.7 Atherosclerosis Market by Regions
  • 7.8 Others Market by Regions

8 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY LOCATION OF TESTING

  • 8.1 Overview by Location of Testing
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Location of Testing
  • 8.4 Point of care Testing Market by Regions
  • 8.5 Laboratory Testing Market by Regions

9 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America
    • 9.3.1. Overview, Historic and Forecast Data
    • 9.3.2. North America By Segment
    • 9.3.3. North America By Country
    • 9.3.4. United State
    • 9.3.5. Canada
    • 9.3.6. Mexico
  • 9.4. Europe
    • 9.4.1. Overview, Historic and Forecast Data
    • 9.4.2. Europe by Segment
    • 9.4.3. Europe by Country
    • 9.4.4. United Kingdom
    • 9.4.5. France
    • 9.4.6. Germany
    • 9.4.7. Italy
    • 9.4.8. Russia
    • 9.4.9. Rest Of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Overview, Historic and Forecast Data
    • 9.5.2. Asia Pacific by Segment
    • 9.5.3. Asia Pacific by Country
    • 9.5.4. China
    • 9.5.5. India
    • 9.5.6. Japan
    • 9.5.7. South Korea
    • 9.5.8. Australia
    • 9.5.9. Rest Of Asia Pacific
  • 9.6. Latin America
    • 9.6.1. Overview, Historic and Forecast Data
    • 9.6.2. Latin America by Segment
    • 9.6.3. Latin America by Country
    • 9.6.4. Brazil
    • 9.6.5. Argentina
    • 9.6.6. Peru
    • 9.6.7. Chile
    • 9.6.8. Rest of Latin America
  • 9.7. Middle East & Africa
    • 9.7.1. Overview, Historic and Forecast Data
    • 9.7.2. Middle East & Africa by Segment
    • 9.7.3. Middle East & Africa by Country
    • 9.7.4. Saudi Arabia
    • 9.7.5. UAE
    • 9.7.6. Israel
    • 9.7.7. South Africa
    • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE CARDIAC BIOMARKERS COMPANIES

  • 10.1. Cardiac Biomarkers Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CARDIAC BIOMARKERS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Roche Diagnostics
    • 11.3.1. Company Overview
    • 11.3.2. Financials
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Abbott Laboratories
    • 11.4.1. Company Overview
    • 11.4.2. Financials
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Siemens Healthcare
    • 11.5.1. Company Overview
    • 11.5.2. Financials
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Alere Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financials
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Becton
    • 11.7.1. Company Overview
    • 11.7.2. Financials
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Dickinson and Company
    • 11.8.1. Company Overview
    • 11.8.2. Financials
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Bio-Rad Laboratories
    • 11.9.1. Company Overview
    • 11.9.2. Financials
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. BioMerieux
    • 11.10.1. Company Overview
    • 11.10.2. Financials
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Randox laboratories
    • 11.11.1. Company Overview
    • 11.11.2. Financials
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Beckman Coulter
    • 11.12.1. Company Overview
    • 11.12.2. Financials
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Thermo Fisher Scientific
    • 11.13.1. Company Overview
    • 11.13.2. Financials
    • 11.13.3. Products
    • 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Type (USD MN)
  • Myocardial muscle Creatine Kinase (CK-MB) Market by Geography (USD MN)
  • Troponins (T and I) Market by Geography (USD MN)
  • Myoglobin Market by Geography (USD MN)
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP Market by Geography (USD MN)
  • Ischemia Modified Albumin (IMA) Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Myocardial Infarction Market by Geography (USD MN)
  • Congestive Heart Failure Market by Geography (USD MN)
  • Acute Coronary Syndrome Market by Geography (USD MN)
  • Atherosclerosis Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Location of Testing (USD MN)
  • Point of care Testing Market by Geography (USD MN)
  • Laboratory Testing Market by Geography (USD MN)
  • Global Cardiac Biomarkers Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Cardiac Biomarkers Report
  • Market Research Process
  • Market Research Methodology
  • Global Cardiac Biomarkers Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Location of Testing
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Myocardial muscle Creatine Kinase (CK-MB) Market by Geography (USD MN)
  • Troponins (T and I) Market by Geography (USD MN)
  • Myoglobin Market by Geography (USD MN)
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP Market by Geography (USD MN)
  • Ischemia Modified Albumin (IMA) Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Myocardial Infarction Market by Geography (USD MN)
  • Congestive Heart Failure Market by Geography (USD MN)
  • Acute Coronary Syndrome Market by Geography (USD MN)
  • Atherosclerosis Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Location of Testing (USD MN)
  • Point of care Testing Market by Geography (USD MN)
  • Laboratory Testing Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.